Lansoprazole-13C6 |
|
| Synonyms: 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-13C6; A-65006-13C6; AG-1749-13C6; Agopton-13C6; Lansox-13C6; Lanzor-13C6; Limpidex-13C6; Ogast-13C; Prevacid-`13C; | |
| Cat. No.: L11141 | CAS No.: 1261394-42-6/103577-45-3(unlabelled) |
| MDL.: | Formula: C1013C6H14F3N3O2S |
| F.W.375.32 | Purity: 99% |
| Storage: No Data Available | |
|   | |
| Catalog Number: | L11141 | CAS No.: | 1261394-42-6/103577-45-3(unlabelled) | |
| MDL: | Formula: | C1013C6H14F3N3O2S | ||
| F.W.: | 375.32 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Figgitt, D., et al.: Drugs, 60, 925 (2000), Katsuki, H., et al.: Eur. J. Clin. Pharmacol., 57, 709 (2001), Barradell, L.B., et al.: Drugs, 44, 225 (1992),Kim, K., et al.: Clin. Pharmacol. Ther., 72, 90 (2002), Niioka, T., et al.: Ther. Drug Monit., 28, 321 (2006), | |||
| Application: | Labelled Lansoprazole (L175000), used as a gastric proton pump inhibitor. An antiulcerative. | |||
| Category: | Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds | |||








